Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases
Epimedium brevicornu (Yin Yang Huo), a widely used traditional Chinese medicinal ingredient, has garnered significant attention for its role in treating orthopedic diseases such as osteoporosis. Our work through network pharmacology and bioinformatics analysis, we identified that out of 27 major act...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1628602/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849390640646848512 |
|---|---|
| author | Dan Tong Long Chen Zeyi Jiang Xuxia Ye Mengjie Ma Angzhi Ye Jian Xu |
| author_facet | Dan Tong Long Chen Zeyi Jiang Xuxia Ye Mengjie Ma Angzhi Ye Jian Xu |
| author_sort | Dan Tong |
| collection | DOAJ |
| description | Epimedium brevicornu (Yin Yang Huo), a widely used traditional Chinese medicinal ingredient, has garnered significant attention for its role in treating orthopedic diseases such as osteoporosis. Our work through network pharmacology and bioinformatics analysis, we identified that out of 27 major active components in Epimedium brevicornu, 8 key components have therapeutic effects on 11 types of diseases related to orthopedic conditions. The disease-target association analysis indicated that Osteoarthritis, Osteoporosis, Muscle Spasm and Myopathy have relatively clear targets for disease treatment. The KEGG enrichment analysis results indicate that the signaling pathway of Epimedium treatment in Osteoarthritis may be closely related to the Lipid and atherosclerosis pathway, PPAR signaling pathway and Arachidonic acid metabolism. Epimedium may treat osteoporosis with Nitrogen metabolism, GABAergic synapse, and Pathways in cancer. Epimedium may affect muscle spasticity through Neuroactive ligand-receptor interaction, Serotonergic synapse and Cholinergic synapse closely related to nervous system function; Additionally, our analysis suggests that Epimedium may treat myopathy through Nitrogen metabolism and GABAergic synapse pathways. These studies have not only provided a molecular mechanism-based explanation for the pharmacological effects of Epimedium, but also laid a theoretical foundation for the development of Epimedium-based precision therapeutic regimens. |
| format | Article |
| id | doaj-art-cbb98f314aff4fff99bc382d997f6307 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-cbb98f314aff4fff99bc382d997f63072025-08-20T03:41:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-08-011610.3389/fphar.2025.16286021628602Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseasesDan Tong0Long Chen1Zeyi Jiang2Xuxia Ye3Mengjie Ma4Angzhi Ye5Jian Xu6Department of Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, ChinaSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Clinical Laboratory, Traditional Chinese Medical Hospital of Zhuji, Zhuji, Zhejiang, ChinaSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, ChinaEpimedium brevicornu (Yin Yang Huo), a widely used traditional Chinese medicinal ingredient, has garnered significant attention for its role in treating orthopedic diseases such as osteoporosis. Our work through network pharmacology and bioinformatics analysis, we identified that out of 27 major active components in Epimedium brevicornu, 8 key components have therapeutic effects on 11 types of diseases related to orthopedic conditions. The disease-target association analysis indicated that Osteoarthritis, Osteoporosis, Muscle Spasm and Myopathy have relatively clear targets for disease treatment. The KEGG enrichment analysis results indicate that the signaling pathway of Epimedium treatment in Osteoarthritis may be closely related to the Lipid and atherosclerosis pathway, PPAR signaling pathway and Arachidonic acid metabolism. Epimedium may treat osteoporosis with Nitrogen metabolism, GABAergic synapse, and Pathways in cancer. Epimedium may affect muscle spasticity through Neuroactive ligand-receptor interaction, Serotonergic synapse and Cholinergic synapse closely related to nervous system function; Additionally, our analysis suggests that Epimedium may treat myopathy through Nitrogen metabolism and GABAergic synapse pathways. These studies have not only provided a molecular mechanism-based explanation for the pharmacological effects of Epimedium, but also laid a theoretical foundation for the development of Epimedium-based precision therapeutic regimens.https://www.frontiersin.org/articles/10.3389/fphar.2025.1628602/fullepimediumorthopedic diseasestargetenrichment analysispathway |
| spellingShingle | Dan Tong Long Chen Zeyi Jiang Xuxia Ye Mengjie Ma Angzhi Ye Jian Xu Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases Frontiers in Pharmacology epimedium orthopedic diseases target enrichment analysis pathway |
| title | Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| title_full | Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| title_fullStr | Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| title_full_unstemmed | Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| title_short | Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| title_sort | progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases |
| topic | epimedium orthopedic diseases target enrichment analysis pathway |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1628602/full |
| work_keys_str_mv | AT dantong progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT longchen progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT zeyijiang progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT xuxiaye progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT mengjiema progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT angzhiye progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases AT jianxu progressintheapplicationofepimediumanditsmajorbioactivecomponentsinthetreatmentoforthopedicdiseases |